Platelet Agregation in Patients on ECMO

NCT05542134 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2023-05-12

No results posted yet for this study

Summary

An observational study in which investigators will observe platelet inhibition in patients on VA ECMO acorrding to treatment with P2Y12 inhibitor.

Conditions

  • Platelet Refractoriness

Interventions

DIAGNOSTIC_TEST

P2Y12 Platelet Aggregation Inhibitor

Verify now PRU test

Sponsors & Collaborators

  • University Medical Centre Ljubljana

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-17
Primary Completion
2023-06-01
Completion
2023-06-01

Countries

  • Slovenia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05542134 on ClinicalTrials.gov